Abstract:Inflammatory bowel diseases (IBD) are a group of chronic inflammatory conditions of the gastrointestinal tract associated with multiple pathogenic factors, including dysregulation of the immune response. Effector CD4 + T cells and regulatory CD4 + T cells (Treg) are central players in maintaining the balance between tolerance and inflammation. Interestingly, genetic modifications in these cells have been implicated in regulating the commitment of specific phenotypes and immune functions. However, the transcriptional program controlling the pathogenic behavior of T helper cells in IBD progression is still unknown. In this study, we aimed to find master transcription regulators controlling the pathogenic behavior of effector CD4 + T cells upon gut inflammation. To achieve this goal, we used an animal model of IBD induced by the transfer of naïve CD4 + T cells into recombination-activating gene 1 ( Rag1 ) deficient mice, which are devoid of lymphocytes. As a control, a group of Rag1 −/− mice received the transfer of the whole CD4 + T cells population, which includes both effector T cells and Treg. When gut inflammation progressed, we isolated CD4 + T cells from the colonic lamina propria and spleen tissue, and performed bulk RNA-seq. We identified differentially up- and down-regulated genes by comparing samples from both experimental groups. We found 532 differentially expressed genes (DEGs) in the colon and 30 DEGs in the spleen, mostly related to Th1 response, leukocyte migration, and response to cytokines in lamina propria T-cells. We integrated these data into Gene Regulatory Networks to identify Master Regulators, identifying four up-regulated master gene regulators (Lef1, Dnmt1, Mybl2, and Jup ) and only one down-regulated master regulator ( Foxo3 ). The altered expression of master regulators observed in the transcriptomic analysis was confirmed by qRT-PCR analysis and found an up-regulation of Lef1 and Mybl2 , but without differences on Dnmt1, Jup, and Foxo3 . These two master regulators have been involved in T cells function and cell cycle progression, respectively. We identified two master regulator genes associated with the pathogenic behavior of effector CD4 + T cells in an animal model of IBD. These findings provide two new potential molecular targets for treating IBD.

Wnt/β-catenin activation epigenetically reprograms Regulatory T cells in IBD and progression to dysplasia.

Wnt–β-catenin activation epigenetically reprograms Treg cells in inflammatory bowel disease and dysplastic progression

Dysregulation of Wnt/β-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells

Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer

TGF-|[bgr]|1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4|[plus]|Foxp3|[plus]| regulatory T cells

Identification of master regulator genes controlling pathogenic CD4+ T cell fate in inflammatory bowel disease through transcriptional network analysis

Epithelial CRL4 DCAF2 is Critical for Maintaining Intestinal Homeostasis Against DSS-Induced Colitis by Regulating the Proliferation and Repair of Intestinal Epithelial Cells

Dysregulated Lysine Acetyltransferase 2b Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10

WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers

Deletion of TNF in Winnie- APCMin/+ Mice Reveals Its Dual Role in the Onset and Progression of Colitis-Associated Colorectal Cancer

Multiplex spatial omics reveals changes in immune-epithelial crosstalk during inflammation and dysplasia development in chronic IBD patients

Transcriptional modulation of pattern recognition receptors in acute colitis in mice

WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer

β-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancer.

The REGγ-proteasome Forms a Regulatory Circuit with IκBɛ and NFκB in Experimental Colitis

WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment

Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer

ZEB1 and TCF4 Reciprocally Modulate Their Transcriptional Activities to Regulate Wnt Target Gene Expression

WNT5A Transforms Intestinal CD8αα+ IELs into an Unconventional Phenotype with Pro-Inflammatory Features

Characterization of novel CD8+ regulatory T cells and their modulatory effects in murine model of inflammatory bowel disease

TLR2-dependent Activation of Β-Catenin Pathway in Dendritic Cells Induces Regulatory Responses and Attenuates Autoimmune Inflammation.